Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Targeting CD169+ skin macrophages may help treat psoriasis.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Combining high-dose corticosteroids with methotrexate may be effective and safe for severe alopecia areata.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Reflectance confocal microscopy is a useful, non-invasive tool for diagnosing some skin diseases, with potential for future improvements.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Upadacitinib effectively treats psoriasis and lichen planus together.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Biological therapy boosts the immune system to effectively fight melanoma.

IL-12/23 inhibitors are more effective and have fewer common side effects than anti-TNF alpha for treating psoriasis.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Abrocitinib may effectively treat stubborn alopecia universalis.

Brodalumab is more effective than ustekinumab for treating psoriasis.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.